Valneva COVID-19 vaccine trial
The Valneva “Cov-Compare” trial
There are several COVID-19 vaccines, both approved and in development. Each one uses a different technology to prevent people from getting sick after being infected by the virus.
Valneva’s Phase 3 clinical trial will test a new vaccine (known as VLA2001) against COVID-19 and its ability to induce antibodies as a protection against the virus.
The trial is now recruiting 4,000 people aged 18 years and over in the UK to help evaluate the VLA2001 vaccine compared to a licensed COVID-19 vaccine.
NUH is one of the locations that you can take part in this trial.
How you can take part
To find out more about the trial and to register to take part, please visit the trial website: https://www.ukcovid19study.com
If you are eligible to take part, then you will be invited to an appointment at the QMC site.
For more information
This trial is being managed by the team of research experts who work as part of the NIHR Nottingham Clinical Research Facility which is based at NUH.